In attempts to identify the metabolic dependencies because of disrupted IDH function, Tateishi et al. found the profound vulnerability of IDH1 mutant glioma cells to the depletion of the NAD+ cofactor [136]. This evidence concerns the gene IDH1 and central nervous system cancer.